Press Releases

GlobeNewswire, Inc.

Study met primary endpoint of mean Total Improvement Score (TIS) at Week 52 in the combined study population of IMNM and DM patients (p=0.0011) Patient improvements observed early and sustained throughout study; consistent treatment effect across...

EIN Presswire

Swiss watch output halved since 2000 while export revenue nearly tripled to $31 billion, a new report on the luxury market found.

GlobeNewswire, Inc.

The only FDA-approved ophthalmic bevacizumab, LYTENAVATM, addresses a significant need in the U.S. wet AMD market where bevacizumab is already widely used Advancing the U.S. launch strategy for LYTENAVA, including broad market access,...

EIN Presswire

68% of tested smartwatch bands show PFAS. Graphene-X rebuilds the 1973 NATO British military strap PFAS free: graphene yarn and Grade 2 titanium hardware.

EIN Presswire

Get audit-ready, compliant KYB/AML, due diligence.

EIN Presswire

Focusing on intelligent retrofit solutions, energy-saving technologies, and safety upgrades for aging elevator fleets.

EIN Presswire

Core Challenge in Global Cancer Control: The Critical Value of Early Screening & Diagnosis HUSTON, TX, UNITED STATES, August 17, 2026 /⁨EINPresswire.com⁩/ -- A widespread global concern in oncology care is that most patients receive a latestage...

GlobeNewswire, Inc.

Topline data from CHAPTER-3, a pivotal Phase 3 study of deucrictibant XR for the prophylaxis of HAE attacks, expected in 3Q2026 Deucrictibant IR NDA under review by the FDA with PDUFA date of April 23, 2027; MAA validated by the EMA in July 2026...

GlobeNewswire, Inc.

GENEVA, Aug. 12, 2026 (GLOBE NEWSWIRE) -- colb.finance today announced that its Swiss entity, Colb Asset SA, operates within a Swiss-compliant legal and regulatory framework for the offering of tokenized pre-IPO structured products under the Swiss...

EIN Presswire

MAULBURG, GERMANY, August 12, 2026 /⁨EINPresswire.com⁩/ -- According to numbers from the German Aerospace Center, more than 36 million flights took off in 2024, making air traffic responsible for approximately 2.1 % of global CO2 emissions.

GlobeNewswire, Inc.

Announced positive interim Phase 1 data from the HEADLINE™ trial of ABS-201 Completed $100 million underwritten offering, including $40 million strategic investment from Eli Lilly & Company Cash, cash equivalents, and marketable securities now...

EIN Presswire

Under the multi-year agreement, Limos4 will be in charge of guest transportation planning, dispatch, and on-site coordination for ZFF beginning in 2026. ZURICH, SWITZERLAND, August 10, 2026 /⁨EINPresswire.com⁩/ -- The Swiss-headquartered...

GlobeNewswire, Inc.

VANCOUVER, British Columbia, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Swiss Water Decaffeinated Coffee Inc. (TSX:SWP) (“Swiss Water” or “the Company”), a leading specialty coffee company and premium chemical-free coffee decaffeinator, today reported...

GlobeNewswire, Inc.

NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Newsweek, in partnership with Statista, the world-leading statistics portal and industry ranking provider, today announced the inaugural World's Greenest Hospitals 2026 ranking, recognizing 250 hospitals...

GlobeNewswire, Inc.

MYQORZO® (aficamten) Net Product Revenue of $25 Million Full Results from ACACIA-HCM to be Presented in Hot Line Session at ESC; Expect to Submit Supplemental NDA for Aficamten in Non-Obstructive HCM in Q4 2026 MYQORZO Launched in Germany,...

GlobeNewswire, Inc.

U.S. Amtagvi Revenue Reaches ~$91M and Total Revenue Increased 66% Year-over-Year Gross Margin Increased to 56% Fast Track Designation (FTD) Granted by the FDA for Lifileucel in Soft Tissue Sarcomas SAN CARLOS, Calif., Aug. 06, 2026 (GLOBE...

GlobeNewswire, Inc.

Commercial preparations for brepocitinib in dermatomyositis (DM) are progressing well and on track for launch by the end of September 2026; topline data from Phase 3 study in non-infectious uveitis (NIU) expected in the second half of calendar...

GlobeNewswire, Inc.

— First global Phase III trial to show significant progression-free and overall survival benefits in this setting — — SAFFRON trial results reinforce TAGRISSO® as the backbone therapy across EGFRm lung cancer — HONG KONG and SHANGHAI and FLORHAM...

GlobeNewswire, Inc.

VANCOUVER, British Columbia, July 30, 2026 (GLOBE NEWSWIRE) -- Swiss Water Decaffeinated Coffee Inc. (TSX: SWP) ("Swiss Water" or "the Company"), a leading specialty coffee company and premium chemical free coffee decaffeinator, announced today...

GlobeNewswire, Inc.

NEW YORK and ZURICH, Aug. 04, 2026 (GLOBE NEWSWIRE) -- As a landmark year for European companies in the U.S. public markets continues to build momentum, the Europe SPAC Summit will convene the dealmakers driving the region's de-SPAC renaissance,...